Other analysts have also recently issued reports about the stock. Stephens initiated coverage on shares of Itron in a research note on Monday, July 8th. They issued an “equal weight” rating and a $64.00 target price for the company. Robert W. Baird reaffirmed an “outperform” rating and issued a $80.00 target price (up from $70.00) on shares of Itron in a research note on Wednesday, September 18th. Credit Suisse Group cut shares of Itron to an “outperform” rating in a research note on Tuesday, August 20th. Raymond James lifted their target price on shares of Itron from $75.00 to $82.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Finally, TheStreet raised shares of Itron from a “c+” rating to a “b-” rating in a research note on Friday, August 16th. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $73.40.
Shares of ITRI opened at $77.28 on Friday. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.44 and a quick ratio of 1.09. The firm has a 50 day simple moving average of $73.35 and a 200-day simple moving average of $62.47. Itron has a 1-year low of $44.35 and a 1-year high of $77.80. The stock has a market cap of $3.02 billion, a price-to-earnings ratio of 29.16, a price-to-earnings-growth ratio of 1.05 and a beta of 1.08.
Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Monday, August 5th. The scientific and technical instruments company reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.39. Itron had a net margin of 2.52% and a return on equity of 19.51%. The business had revenue of $635.04 million during the quarter, compared to analysts’ expectations of $598.59 million. During the same period last year, the company posted $0.51 EPS. The company’s revenue was up 8.4% on a year-over-year basis. On average, equities analysts expect that Itron will post 2.9 earnings per share for the current fiscal year.
In other Itron news, Director Thomas S. Glanville sold 1,000 shares of Itron stock in a transaction on Friday, October 11th. The shares were sold at an average price of $75.10, for a total value of $75,100.00. Following the transaction, the director now owns 11,056 shares in the company, valued at approximately $830,305.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Thomas S. Glanville sold 3,000 shares of Itron stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $66.38, for a total transaction of $199,140.00. Following the completion of the transaction, the director now owns 13,007 shares in the company, valued at approximately $863,404.66. The disclosure for this sale can be found here. Insiders sold a total of 77,667 shares of company stock valued at $5,585,025 over the last ninety days. 2.35% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently made changes to their positions in ITRI. Clearbridge Investments LLC increased its stake in shares of Itron by 13.6% in the 1st quarter. Clearbridge Investments LLC now owns 441,200 shares of the scientific and technical instruments company’s stock valued at $20,582,000 after purchasing an additional 52,656 shares in the last quarter. FMR LLC increased its stake in shares of Itron by 3.1% in the 1st quarter. FMR LLC now owns 253,752 shares of the scientific and technical instruments company’s stock valued at $11,837,000 after purchasing an additional 7,614 shares in the last quarter. Oregon Public Employees Retirement Fund increased its stake in shares of Itron by 1.5% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 13,175 shares of the scientific and technical instruments company’s stock valued at $824,000 after purchasing an additional 200 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Itron by 145.4% in the 2nd quarter. Versant Capital Management Inc now owns 697 shares of the scientific and technical instruments company’s stock valued at $43,000 after purchasing an additional 413 shares in the last quarter. Finally, AE Wealth Management LLC purchased a new position in shares of Itron in the 2nd quarter valued at about $492,000. Institutional investors own 94.31% of the company’s stock.
Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
Featured Story: Stocks at 52 Week High
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.